[A11-31] Tafamidis - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 15.03.2012
Project no.:
A11-31
Commission:
Commission awarded on 14.12.2011 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Application field:
Head and nerves
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A20-101 | Tafamidis (transthyretin amyloidosis) - Benefit assessment according to §35a Social Code Book V | Commission completed |
| A20-102 | Tafamidis (transthyretin amyloidosis with cardiomyopathy) - Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2012-06-07 A G-BA decision was published.